The contemporary convergence of high-performance graphics processing units and data-intensive biomedical analytics has generated a new epistemic space in which computational reliability, diagnostic automation, and clinical interpretation increasingly overlap. Digital pathology, genomic variant detection, and large-scale clinical image analysis now rely on massive parallelism delivered by modern GPUs, yet the operational reliability of such hardware has historically been treated as a secondary engineering concern rather than a foundational determinant of scientific and clinical validity. This article develops a comprehensive theoretical and applied framework for understanding factory-grade GPU diagnostic automation as a central enabling condition for trustworthy digital pathology and computational inference. Drawing on recent advances in automated GPU health verification and failure detection, particularly the factory-grade diagnostic architecture proposed for GeForce and data centre GPUs by Lulla, Chandra, and Ranjan (2025), the study argues that hardware-level reliability testing must be understood as an epistemological pillar of modern digital diagnostics rather than a peripheral technical service.

The article integrates three major literatures that are rarely placed in sustained dialogue: formal methods and satisfiability theory, GPU-based high-performance computing, and the rapidly expanding field of digital pathology. The historical trajectory of automated reasoning, from early theorem proving systems to modern incremental satisfiability and model checking, provides a conceptual lens for interpreting GPU diagnostics as a form of hardware-level verification analogous to logical consistency checking in software systems (Davis et al., 1962; Een and Sorensson, 2003; Emerson and Halpern, 1983). At the same time, performance-oriented GPU studies and biomedical computing frameworks demonstrate that even minor undetected hardware faults can propagate through massively parallel workloads to produce clinically misleading outputs in digital pathology, genomic epidemiology, and artificial intelligence-based diagnostics (Fang et al., 2011; Carpi et al., 2022; Waqas et al., 2023). By synthesizing these bodies of work, this article establishes that factory-grade GPU diagnostic automation is not only a technical safeguard but also a methodological prerequisite for reproducible, safe, and ethically defensible biomedical inference.

Methodologically, the study employs a theory-driven integrative review and conceptual modeling approach. Instead of empirical benchmarking, it constructs an interpretive framework that maps GPU diagnostic stages to stages of formal verification and to phases of digital pathology workflows. The results demonstrate that systematic, automated GPU diagnostics reduce epistemic risk by stabilizing computational substrates upon which clinical AI and digital microscopy operate. The discussion elaborates the implications for regulatory science, laboratory accreditation, and future GPU-enabled clinical platforms, arguing that the absence of factory-grade diagnostic automation constitutes an unrecognized form of clinical risk. The article concludes that the integration of automated GPU diagnostics into biomedical computing pipelines is a necessary condition for the future of precision medicine, particularly as generative and foundation models increasingly mediate diagnostic decision-making.